Dr. Pavan Raghava Reddy Kalluri

   MBBS, MD (General Medicine), DM (Medical Oncology)

Book An Appointment

Home / Doctors / Dr. Pavan Raghava Reddy Kalluri

Dr. Pavan Raghava Reddy Kalluri

Consultant – Medical Oncology


MBBS, MD (General Medicine), DM (Medical Oncology)


Medical Oncology


HCG Curie City Cancer Centre, Vijayawada


7+ Years

  • Dr. Pavan Raghava Reddy Kalluri is a consultant – medical oncology, practising at the HCG Cancer Centre, Vijayawada.
  • He has vast experience in administering multiple systemic therapies, such as chemotherapy, immunotherapy, and targeted therapy. He is also trained in performing bone marrow transplantation procedures (auto and allo-HSCT).
  • Dr. Pavan has also received training in procedures like central line insertions, bone marrow biopsy, lumbar puncture, etc.
  • His primary expertise lies in the management of haematological, breast, and gynaecological malignancies. He is also an expert in the management of head and neck cancers and lung cancer.
  • Along with these, Dr. Pavan is also experienced in cancer pain management and delivering palliative/terminal care for patients in terminal stages.
  • Dr. Pavan has a keen interest in research and is skilled at designing and conducting clinical trials.
  • Dr. Pavan has had an illustrious academic career both at the undergraduate and postgraduate levels and has bagged several awards and accolades during these years.
  • He has secured a medal in the All-India COPE exam conducted by the Cancer Institute (WIA).
  • Dr. Pavan holds memberships with several reputed medical associations, such as ISMPO, ESMO, ACORD (Clinical Trial Design Development), and IMA.
  • A study of cytogenetics and outcomes in acute lymphoblastic leukaemia in the Indian Journal of Haematology and Blood Transfusion - Reddy, P., Shankar, R., Koshy, T. et al. Indian J Hematol Blood Transfus. 2019 Oct; 35(4):640-648
  • A report of the youngest case of multiple myeloma in an 8-year-old child in Journal of Pediatric Hematology/Oncology. - J Pediatr Hematol Oncol. 2017 Jan:39(1):77
  • A case series on Esthesioneuroblastoma - a rare tumour in the University Journal of Medicine and Medical Sciences.
  • Poster presentation on experience with Crizotinib in ALK-positive lung cancer at the Lung Cancer Consortium Asia meeting

   Practices at

Other Doctors